Literature DB >> 8895112

Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic.

T Lyttle1, D Goldstein, J Gartz.   

Abstract

This paper investigates the supposedly psychedelic Bufo toad and the allegedly psychedelic drug bufotenine, which is contained in the skin and glands of this toad. The bufo toad has held a place in human mythologies and medicines worldwide since archaic times. Used by ancient peoples for a variety of purposes, its most spectacular effects, according to lore, involve magical and shamanic or occult uses for casting spells and for divination. In the Middle Ages, the Bufo toad was celebrated as a panacea and persecuted as a powerful poison. More recently, in the 1960s the Bufo toad was resurrected as a countercultural icon, with people purportedly licking or smoking the secretions to get high. Bufotenine has been at the center of a scientific debate since its discovery in 1893. This paper examines the extensive literature surrounding the Bufo toad and bufotenine, and untangles many of the myths and the misinformation that continue to vex both science and popular reporting. Finally, to promote further investigation, a comprehensive bibliography is provided that charts the history of the Bufo toad and bufotenine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895112     DOI: 10.1080/02791072.1996.10472488

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  9 in total

Review 1.  Aphrodisiacs past and present: a historical review.

Authors:  P Sandroni
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

3.  The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.

Authors:  Alan K Davis; Joseph P Barsuglia; Rafael Lancelotta; Robert M Grant; Elise Renn
Journal:  J Psychopharmacol       Date:  2018-04-30       Impact factor: 4.153

4.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

5.  Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.

Authors:  Rafaela Martin; Jennifer Schürenkamp; Angela Gasse; Heidi Pfeiffer; Helga Köhler
Journal:  Int J Legal Med       Date:  2012-11-27       Impact factor: 2.686

Review 6.  Recreational use, analysis and toxicity of tryptamines.

Authors:  Roberta Tittarelli; Giulio Mannocchi; Flaminia Pantano; Francesco Saverio Romolo
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 7.  Venomous and poisonous Australian animals of veterinary importance: a rich source of novel therapeutics.

Authors:  Margaret C Hardy; Jonathon Cochrane; Rachel E Allavena
Journal:  Biomed Res Int       Date:  2014-07-21       Impact factor: 3.411

8.  Biological Effects and Biodistribution of Bufotenine on Mice.

Authors:  Hugo Vigerelli; Juliana Mozer Sciani; Maria Andrea Camarano Eula; Luciana Almeida Sato; Marta M Antoniazzi; Carlos Jared; Daniel C Pimenta
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

9.  Detection of antidiabetic activity by crude paratoid gland secretions from common Indian toad (bufomelano stictus).

Authors:  Prasad Neerati
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.